LONDON - British drug maker GlaxoSmithKline PLC said today that it would cut jobs and costs after fourth-quarter net profit fell 10 percent because of higher research and sales spending as well as legal charges.
LONDON - British drug maker GlaxoSmithKline PLC said today that it would cut jobs and costs after fourth-quarter net profit fell 10 percent because of higher research and sales spending as well as legal charges.